Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jan 3;12(1):363.
doi: 10.3390/jcm12010363.

Dyslipidemia and Cardiovascular Disease: Current Knowledge, Existing Challenges, and New Opportunities for Management Strategies

Zhiyong Du  1   2 , Yanwen Qin  1   2
Affiliations
Editorial

Dyslipidemia and Cardiovascular Disease: Current Knowledge, Existing Challenges, and New Opportunities for Management Strategies

Zhiyong Du et al. J Clin Med. .

Abstract

Cardiovascular disease is the leading cause of morbidity and mortality worldwide, and dyslipidemia is one of the major risk factors [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Pirillo A., Casula M., Olmastroni E., Norata G.D., Catapano A.L. Global epidemiology of dyslipidaemias. Nat. Rev. Cardiol. 2021;18:689–700. doi: 10.1038/s41569-021-00541-4. - DOI - PubMed
    1. Balling M., Nordestgaard B.G., Langsted A., Varbo A., Kamstrup P.R., Afzal S. Small dense low-density lipoprotein cholesterol predicts atherosclerotic cardiovascular disease in the Copenhagen general population study. J. Am. Coll. Cardiol. 2020;75:2873–2875. doi: 10.1016/j.jacc.2020.03.072. - DOI - PubMed
    1. Ference B.A., Ginsberg H.N., Graham I., Ray K.K., Packard C.J., Bruckert E., Hegele R.A., Krauss R.M., Raal F.J., Schunkert H., et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur. Heart J. 2017;38:2459–2472. doi: 10.1093/eurheartj/ehx144. - DOI - PMC - PubMed
    1. Domanski M.J., Tian X., Wu C.O., Reis J.P., Dey A.K., Gu Y., Zhao L., Bae S., Liu K., Hasan A.A., et al. Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk. J. Am. Coll. Cardiol. 2020;76:1507–1516. doi: 10.1016/j.jacc.2020.07.059. - DOI - PubMed
    1. Boren J., Chapman M.J., Krauss R.M., Packard C.J., Bentzon J.F., Binder C.J., Daemen M.J., Demer L.L., Hegele R.A., Nicholls S.J., et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: Pathophysiological, genetic, and therapeutic insights: A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur. Heart J. 2020;41:2313–2330. doi: 10.1093/eurheartj/ehz962. - DOI - PMC - PubMed

Publication types

LinkOut - more resources